Author:
Ozomaro Uzoezi,Wahlestedt Claes,Nemeroff Charles B
Abstract
Abstract
The central theme of personalized medicine is the premise that an individual’s unique physiologic characteristics play a significant role in both disease vulnerability and in response to specific therapies. The major goals of personalized medicine are therefore to predict an individual’s susceptibility to developing an illness, achieve accurate diagnosis, and optimize the most efficient and favorable response to treatment. The goal of achieving personalized medicine in psychiatry is a laudable one, because its attainment should be associated with a marked reduction in morbidity and mortality. In this review, we summarize an illustrative selection of studies that are laying the foundation towards personalizing medicine in major depressive disorder, bipolar disorder, and schizophrenia. In addition, we present emerging applications that are likely to advance personalized medicine in psychiatry, with an emphasis on novel biomarkers and neuroimaging.
Publisher
Springer Science and Business Media LLC
Reference381 articles.
1. Myers AJ, Nemeroff CB: New Vistas in the Management of Treatment-Refractory Psychiatric Disorders: Genomics and Personalized Medicine. Focus. 2010, 8: 525-535.
2. Mehta R, Jain RK, Badve S: Personalized medicine: the road ahead. Clin Breast Cancer. 2011, 11: 20-26.
3. Conneally PM: Huntington disease: genetics and epidemiology. Am J Hum Genet. 1984, 36: 506-526.
4. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994, 51: 8-19.
5. Risch SC, Nemeroff CB: Neurochemical alterations of serotonergic neuronal systems in depression. J Clin Psychiatry. 1992, 53: 3-7.
Cited by
221 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献